The diastereoselective, trichlorosilane-mediate reduction of imines, bearing different and removable chiral auxiliaries, in combination either with achiral bases or catalytic amounts of chiral Lewis bases, was investigated to afford immediate precursors of chiral APIs (Active Pharmaceutical Ingredients). The carbon-nitrogen double bond reduction was successfully performed in batch and in flow mode, in high yields and almost complete stereocontrol. By this metal-free approach, the formal synthesis of rasagiline and tamsulosin was successfully accomplished in micro(meso) flow reactors, under continuous flow conditions. The results of these explorative studies represent a new, important step towards the development of automated processes for the preparation of enantiopure biologically active compounds
A stereoselective, catalytic strategy for the in-flow synthesis of advanced precursors of Rasagiline and Tamsulosin / D. Brenna, M. Pirola, L. Raimondi, A.J. Burke, M. Benaglia. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 25:23(2017 Dec 01), pp. 6242-6247. [10.1016/j.bmc.2017.01.023]
A stereoselective, catalytic strategy for the in-flow synthesis of advanced precursors of Rasagiline and Tamsulosin
D. Brenna;M. Pirola;L. Raimondi;M. Benaglia
2017
Abstract
The diastereoselective, trichlorosilane-mediate reduction of imines, bearing different and removable chiral auxiliaries, in combination either with achiral bases or catalytic amounts of chiral Lewis bases, was investigated to afford immediate precursors of chiral APIs (Active Pharmaceutical Ingredients). The carbon-nitrogen double bond reduction was successfully performed in batch and in flow mode, in high yields and almost complete stereocontrol. By this metal-free approach, the formal synthesis of rasagiline and tamsulosin was successfully accomplished in micro(meso) flow reactors, under continuous flow conditions. The results of these explorative studies represent a new, important step towards the development of automated processes for the preparation of enantiopure biologically active compoundsFile | Dimensione | Formato | |
---|---|---|---|
biorg med chem 2017.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
774.33 kB
Formato
Adobe PDF
|
774.33 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
rev bioor medchem flow.pdf
accesso aperto
Descrizione: post print
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
278.8 kB
Formato
Adobe PDF
|
278.8 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.